ISRCTN45181565
Completed
Not Applicable
A prospective randomised controlled trial into the role of hydrotherapy and physiotherapy in reducing the incapacity during acute phase of Legg-Calve-Perthes disease
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 sites0 target enrollmentSeptember 12, 2003
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Musculoskeletal Diseases: Legg-Perthes disease
- Sponsor
- Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with acute phase of Legg\-Calve\-Perthes disease
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A prospective randomised controlled trial of management of recurrent nosebleeds in children: antiseptic cream alone versus antiseptic cream with nasal cauteryRecurrent Paediatric EpistaxisEUCTR2005-006089-32-GBHS Greater Glasgow - Yorkhill Division216
Completed
Not Applicable
The Use of Intravenous Fluids in Acute Ureteric Colicreteric ColicUreteric ColicRenal and Urogenital - Other renal and urogenital disordersACTRN12610000227099Dr Adeline Wu70
Not yet recruiting
Phase 3
A study to improve the pain management, early recovery and less hospital stay after caesarean deliveryCTRI/2024/07/070886Shri B M Patil Medical College and hospital
Completed
Not Applicable
A prospective randomized controlled trial to investigate the effect of early administration of antibiotics for patients with suspected sepsisNL-OMON43665Vrije Universiteit Medisch Centrum2,800
Active, not recruiting
Not Applicable
A prospective open randomised controlled trial of women diagnosed with premature ovarian failure (POF) to investigate the effects of active treatment with HRT (hormone replacement therapy) or COCP (combined oral contraceptive pill), and observation of patients who choose to have no treatment, on bone density, markers of cardiovascular disease, markers of bone metabolism, menopausal symptoms, quality of life, depression score, sexual function and ovarian function over 2 years. - Treatment of Premature Ovarian FailureEUCTR2008-002599-86-GBGuy's and St Thomas Foundation NHS Trust66